Chlorphenamine Maleate API Market Size is valued at USD 70.2 Mn in 2023 and is predicted to reach USD 120.5 Mn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Chlorphenamine maleate is an important active pharmaceutical ingredient (API) in the pharmaceutical industry due to its proven effectiveness and wide range of uses in treating symptoms related to different allergic responses. The Chlorphenamine maleat...
Report ID: 2463 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Gene Therapy on Cardiovascular Disease Market Size is predicted to grow at a 67.4% CAGR during the forecast period for 2024-2031. Gene therapy for cardiovascular disease shows promising potential but is primarily in the experimental and clinical trial stages. Achievement in this domain has the potential to result in groundbreaking therapies for conditions that presently possess restricted therapeutic alternatives. One approach to gene therapy ...
Report ID: 2451 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Microbiome Manufacturing Market Size is valued at USD 27.3 Mn in 2023 and is predicted to reach USD 84.8 Mn by the year 2031 at a 15.4% CAGR during the forecast period for 2024-2031. Microbiome manufacture integrates sophisticated biotechnological techniques with a deep comprehension of microbial ecosystems, rendering it a state-of-the-art field of advancement with extensive implications for medicine, nutrition, and general health. The microbi...
Report ID: 2458 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size is valued at USD 5.4 Bn in 2023 and is predicted to reach USD 10.8 Bn by the year 2031 at a 9.3% CAGR during the forecast period for 2024-2031 Both liposomal and lipid nanoparticle systems are notable advancements in drug delivery technology, specifically for delivering therapeutic compounds that are challenging to administer due to stability or toxicity concerns. Their progres...
Report ID: 2459 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Levonorgestrel API Market Size was valued at USD 52.01 Mn in 2023 and is predicted to reach USD 71.37 Mn by 2031 at a 4.13% CAGR during the forecast period for 2024-2031. Levonorgestrel is a medicine that is mostly prescribed for the purpose of preventing pregnancy. There are many ways to actively use this hormone drug to control birth. If all other methods of preventing pregnancy have been exhausted, an emergency contraceptive may be utilized...
Report ID: 2460 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Adrenocortical Hormones API Market Size is valued at USD 2.24 Bn in 2023 and is predicted to reach USD 3.55 Bn by the year 2031 at a 6.04% CAGR during the forecast period for 2024-2031. Adrenocortical hormones, also referred to as corticosteroids or adrenal cortex hormones, are steroid hormones synthesized by the adrenal cortex, which is a component of the adrenal gland. This hormone is synthesized or extracted to be used as API (Active P...
Report ID: 2453 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
The Precision Fluidics Market Size is valued at USD 6.79 Billion in 2023 and is predicted to reach USD 12.63 Billion by the year 2031 at an 8.20 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The expanding use of microfluidics in point-of-care diagnostics and the miniaturization of devices for improved efficiency are further propelling market growth. The lack of awareness and ...
Report ID: 1405 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 175
The Novel Drug Delivery Systems In Cancer Therapy Market Size is valued at USD 12.71 Billion in 2023 and is predicted to reach USD 63.25 Billion by the year 2031 at a 22.41 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The ability of novel drug delivery systems to deliver targeted therapies provides opportunities for personalized medicine. Advances in targeted therapies, including...
Report ID: 1440 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 175
Cervical Spondylosis Diagnosis & Treatment Market Size is valued at USD 6.19 Bn in 2023 and is predicted to reach USD 10.14 Bn by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031. Cervical spondylosis is a degenerative disorder that affects the neck region and is treated with therapy. These therapies reduce discomfort, boost mobility, and forestall nerve and spinal cord degeneration. Pain and stiffness can be experienc...
Report ID: 2430 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Shoulder Replacement Market Size is valued at USD 1.55 Bn in 2022 and is predicted to reach USD 2.62 Bn by the year 2031 at a 6.10% CAGR during the forecast period for 2023-2031. Shoulder arthroplasty, also known as shoulder replacement surgery, involves replacing the ball and sometimes the socket of the shoulder joint using a prosthesis composed of metal and polyethylene components. This surgical procedure is referred to as shoulder arthropla...
Report ID: 2155 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Pharmaceuticals